These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2505614)

  • 1. Recombinant interferon-gamma in the treatment of systemic sclerosis.
    Kahan A; Amor B; Menkes CJ; Strauch G
    Am J Med; 1989 Sep; 87(3):273-7. PubMed ID: 2505614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of systemic sclerosis with gamma-interferon.
    Hein R; Behr J; Hündgen M; Hunzelmann N; Meurer M; Braun-Falco O; Urbanski A; Krieg T
    Br J Dermatol; 1992 May; 126(5):496-501. PubMed ID: 1610690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of systemic sclerosis with recombinant interferon-gamma. A phase I/II clinical trial.
    Freundlich B; Jimenez SA; Steen VD; Medsger TA; Szkolnicki M; Jaffe HS
    Arthritis Rheum; 1992 Oct; 35(10):1134-42. PubMed ID: 1418004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic scleroderma. Multicenter trial of 1 year of treatment with recombinant interferon gamma.
    Hunzelmann N; Anders S; Fierlbeck G; Hein R; Herrmann K; Albrecht M; Bell S; Thur J; Muche R; Adelmann-Grill B; Wehner-Caroli J; Gaus W; Krieg T
    Arch Dermatol; 1997 May; 133(5):609-13. PubMed ID: 9158414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of recombinant gamma interferon in the treatment of systemic sclerosis.
    Vlachoyiannopoulos PG; Tsifetaki N; Dimitriou I; Galaris D; Papiris SA; Moutsopoulos HM
    Ann Rheum Dis; 1996 Oct; 55(10):761-8. PubMed ID: 8984943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter trial of recombinant human interferon gamma in patients with systemic sclerosis: effects on cutaneous fibrosis and interleukin 2 receptor levels.
    Polisson RP; Gilkeson GS; Pyun EH; Pisetsky DS; Smith EA; Simon LS
    J Rheumatol; 1996 Apr; 23(4):654-8. PubMed ID: 8730122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased mitogenic activity of scleroderma serum: inhibitory effect of human recombinant interferon-gamma.
    Bryckaert M; Fontenay M; Lioté F; Bellucci S; Carriou R; Tobelem G
    Ann Rheum Dis; 1994 Nov; 53(11):776-9. PubMed ID: 7826142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha interferon-2a (Roferon-A) in the treatment of diffuse cutaneous systemic sclerosis: a pilot study. UK Systemic Sclerosis Study Group.
    Stevens W; Vancheeswaran R; Black CM
    Br J Rheumatol; 1992 Oct; 31(10):683-9. PubMed ID: 1393375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon gamma in rheumatoid arthritis--a double blind study comparing human recombinant interferon gamma with placebo.
    Veys EM; Mielants H; Verbruggen G; Grosclaude JP; Meyer W; Galazka A; Schindler J
    J Rheumatol; 1988 Apr; 15(4):570-4. PubMed ID: 3135392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-gamma in the treatment of systemic sclerosis: a randomized controlled multicentre trial.
    Grassegger A; Schuler G; Hessenberger G; Walder-Hantich B; Jabkowski J; MacHeiner W; Salmhofer W; Zahel B; Pinter G; Herold M; Klein G; Fritsch PO
    Br J Dermatol; 1998 Oct; 139(4):639-48. PubMed ID: 9892907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy.
    Nathan CF; Kaplan G; Levis WR; Nusrat A; Witmer MD; Sherwin SA; Job CK; Horowitz CR; Steinman RM; Cohn ZA
    N Engl J Med; 1986 Jul; 315(1):6-15. PubMed ID: 3086725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I trial of recombinant human gamma interferon (IFN-gamma 4A) in patients with advanced malignancy.
    Perez R; Lipton A; Harvey HA; Simmonds MA; Romano PJ; Imboden SL; Giudice G; Downing MR; Alton NK
    J Biol Response Mod; 1988 Jun; 7(3):309-17. PubMed ID: 3134513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of progressive scleroderma with gamma-interferon].
    Mensing H
    Hautarzt; 1991 Jun; 42(6):380-3. PubMed ID: 1917461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modulation of the organization of the extracellular matrix and the production of collagen by interferon gamma in three-dimensional cultures of normal and sclerodermic fibroblasts].
    Serpier H; Gillery P; Polette M; Clavel C; Birembaut P; Kalis B; Cariou R; Maquart FX
    Pathol Biol (Paris); 1992 Nov; 40(9):865-70. PubMed ID: 1296158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term results of the treatment of diffuse systemic scleroderma with interferon-gamma].
    Blétry O; Laraki R; Cabane J; Francès C; Piette JC; Soubrier M; Wechsler B; de Gennes C; Valat C; Cosserat J
    Rev Med Interne; 1993; 14(10):978. PubMed ID: 8009071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.
    Weiner LM; Li W; Holmes M; Catalano RB; Dovnarsky M; Padavic K; Alpaugh RK
    Cancer Res; 1994 Aug; 54(15):4084-90. PubMed ID: 8033141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of gamma-1b-interferon in combination with fluorouracil, leucovorin, and alpha-2a-interferon.
    Grem JL; McAtee N; Murphy RF; Balis FM; Cullen E; Chen AP; Hamilton JM; Steinberg SM; Quinn M; Sorensen JM; Arbuck SG; Lawrence D; Pang J; Allegra CJ
    Clin Cancer Res; 1997 Jul; 3(7):1125-34. PubMed ID: 9815792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma-interferon inhibits extracellular matrix synthesis and remodeling in collagen lattice cultures of normal and scleroderma skin fibroblasts.
    Gillery P; Serpier H; Polette M; Bellon G; Clavel C; Wegrowski Y; Birembaut P; Kalis B; Cariou R; Maquart FX
    Eur J Cell Biol; 1992 Apr; 57(2):244-53. PubMed ID: 1511700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma-interferon in myelodysplastic syndromes: a pilot study.
    Schwarzinger I; Stain C; Bettelheim P; Hinterberger W; Lechner K
    Oncology; 1990; 47(4):322-6. PubMed ID: 2114596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy for systemic juvenile rheumatoid arthritis with gamma-interferon: a pilot study of nine patients.
    Pernice W; Schuchmann L; Dippell J; Suschke J; Vogel P; Truckenbrodt H; Schindera F; Humburg C; Brzoska J
    Arthritis Rheum; 1989 May; 32(5):643-6. PubMed ID: 2497750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.